• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表达细胞膜表面非依赖性切割的 HIV Env 三聚体的 mRNA 脂纳米颗粒可诱导自体的 Tier-2 中和抗体。

mRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodies.

机构信息

Wyatt Lab, Department of Immunology and Microbiology, Scripps Research, La Jolla, CA, United States.

Weissman Lab, Penn Institute for RNA Innovation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.

出版信息

Front Immunol. 2024 Jul 25;15:1426232. doi: 10.3389/fimmu.2024.1426232. eCollection 2024.

DOI:10.3389/fimmu.2024.1426232
PMID:39119336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11306127/
Abstract

The HIV-1 envelope glycoprotein (Env) is the sole neutralizing determinant on the surface of the virus. The Env gp120 and gp41 subunits mediate receptor binding and membrane fusion and are generated from the gp160 precursor by cellular furins. This cleavage event is required for viral entry. One approach to generate HIV-1 neutralizing antibodies following immunization is to express membrane-bound Env anchored on the cell-surface by genetic means using the natural HIV gp41 transmembrane (TM) spanning domain. To simplify the process of Env trimer membrane expression we sought to remove the need for Env precursor cleavage while maintaining native-like conformation following genetic expression. To accomplish these objectives, we selected our previously developed 'native flexibly linked' (NFL) stabilized soluble trimers that are both near-native in conformation and cleavage-independent. We genetically fused the NFL construct to the HIV TM domain by using a short linker or by restoring the native membrane external proximal region, absent in soluble trimers, to express the full HIV Env ectodomain on the plasma membrane. Both forms of cell-surface NFL trimers, without and with the MPER, displayed favorable antigenic profiles by flow cytometry when expressed from plasmid DNA or mRNA. These results were consistent with the presence of well-ordered cell surface native-like trimeric Env, a necessary requirement to generate neutralizing antibodies by vaccination. Inoculation of rabbits with mRNA lipid nanoparticles (LNP) expressing membrane-bound stabilized HIV Env NFL trimers generated tier 2 neutralizing antibody serum titers in immunized animals. Multiple inoculations of mRNA LNPs generated similar neutralizing antibody titers compared to immunizations of matched NFL soluble proteins in adjuvant. Given the recent success of mRNA vaccines to prevent severe COVID, these are important developments for genetic expression of native-like HIV Env trimers in animals and potentially in humans.

摘要

HIV-1 包膜糖蛋白(Env)是病毒表面唯一的中和决定簇。Env 的 gp120 和 gp41 亚基介导受体结合和膜融合,由细胞弗林蛋白酶从 gp160 前体中产生。这种切割事件是病毒进入所必需的。免疫接种后产生 HIV-1 中和抗体的一种方法是通过遗传手段使用天然 HIV gp41 跨膜(TM)跨越结构域将膜结合的 Env 表达在细胞表面上。为了简化 Env 三聚体膜表达的过程,我们试图在保持遗传表达后保持天然样构象的同时,去除 Env 前体切割的需要。为了实现这些目标,我们选择了我们之前开发的“天然灵活连接”(NFL)稳定的可溶性三聚体,这些三聚体在构象上非常接近天然,并且不依赖于切割。我们通过使用短接头或恢复可溶性三聚体中缺失的天然膜外近区,将 NFL 结构与 HIV TM 结构域基因融合,在质膜上表达完整的 HIV Env 外结构域。当从质粒 DNA 或 mRNA 表达时,两种形式的细胞膜 NFL 三聚体,无论是带有还是不带有 MPER,在流式细胞术上都显示出有利的抗原谱。这些结果与存在有序的细胞膜上类似天然的三聚体 Env 一致,这是通过接种疫苗产生中和抗体的必要条件。用表达膜结合稳定的 HIV Env NFL 三聚体的 mRNA 脂质纳米颗粒(LNP)接种兔子,在免疫动物中产生了 2 级中和抗体血清滴度。与在佐剂中免疫匹配的 NFL 可溶性蛋白相比,多次接种 mRNA LNPs 产生了类似的中和抗体滴度。鉴于 mRNA 疫苗最近在预防严重 COVID 方面的成功,这些进展对于在动物中,以及在人类中,对天然样 HIV Env 三聚体进行基因表达是重要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/393d5595ed64/fimmu-15-1426232-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/e0190c976719/fimmu-15-1426232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/fe0dcfe673b0/fimmu-15-1426232-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/793ce2048d53/fimmu-15-1426232-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/2f0c2a4fea75/fimmu-15-1426232-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/78367ba673ab/fimmu-15-1426232-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/552200873eec/fimmu-15-1426232-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/a233f6cad1d3/fimmu-15-1426232-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/393d5595ed64/fimmu-15-1426232-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/e0190c976719/fimmu-15-1426232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/fe0dcfe673b0/fimmu-15-1426232-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/793ce2048d53/fimmu-15-1426232-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/2f0c2a4fea75/fimmu-15-1426232-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/78367ba673ab/fimmu-15-1426232-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/552200873eec/fimmu-15-1426232-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/a233f6cad1d3/fimmu-15-1426232-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c451/11306127/393d5595ed64/fimmu-15-1426232-g008.jpg

相似文献

1
mRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodies.表达细胞膜表面非依赖性切割的 HIV Env 三聚体的 mRNA 脂纳米颗粒可诱导自体的 Tier-2 中和抗体。
Front Immunol. 2024 Jul 25;15:1426232. doi: 10.3389/fimmu.2024.1426232. eCollection 2024.
2
Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies.CHO 细胞系产生的无切割依赖性 HIV-1 三聚体引发强烈的自体 Tier 2 中和抗体。
Front Immunol. 2018 May 24;9:1116. doi: 10.3389/fimmu.2018.01116. eCollection 2018.
3
Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.未切割与成熟人免疫缺陷病毒膜包膜糖蛋白三聚体的比较。
J Virol. 2018 May 29;92(12). doi: 10.1128/JVI.00277-18. Print 2018 Jun 15.
4
Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers.由精英中和抗体诱导的 HIV-1 包膜糖蛋白 SOSIP 三聚体产生的中和抗体反应。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.01214-20.
5
Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus.采用 DNA、改良安卡拉痘苗病毒和基于蛋白的疫苗进行初免-加强免疫可诱导针对 CAP256 超感染病毒的强效 HIV-1 2 型中和抗体。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.02155-18. Print 2019 Apr 15.
6
Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.预融合HIV-1包膜三聚体与四级结构特异性抗体复合物的免疫原性
J Virol. 2015 Dec 30;90(6):2740-55. doi: 10.1128/JVI.02380-15.
7
Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes.通过靶向序列改变提高可溶性、重组天然样HIV-1包膜糖蛋白三聚体的表达和纯化
J Virol. 2017 May 26;91(12). doi: 10.1128/JVI.00264-17. Print 2017 Jun 15.
8
Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein.用 HIV-1 分 B 亚型 SOSIP 三聚体免疫的兔子产生的抗体可以通过破坏包膜糖蛋白来中和多种 B 亚型病毒。
J Virol. 2021 Aug 10;95(17):e0009421. doi: 10.1128/JVI.00094-21.
9
Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation.可诱导细胞系产生含有以预触发构象稳定化的包膜糖蛋白的复制缺陷型人类免疫缺陷病毒颗粒。
J Virol. 2024 Dec 17;98(12):e0172024. doi: 10.1128/jvi.01720-24. Epub 2024 Nov 7.
10
Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor.HIV-1 包膜三聚体与小分子病毒进入抑制剂复合物的抗原性和免疫原性。
J Virol. 2020 Oct 14;94(21). doi: 10.1128/JVI.00958-20.

引用本文的文献

1
Vaccination with an mRNA-encoded membrane-bound HIV envelope trimer induces neutralizing antibodies in animal models.用mRNA编码的膜结合HIV包膜三聚体进行疫苗接种可在动物模型中诱导中和抗体。
Sci Transl Med. 2025 Jul 30;17(809):eadw0721. doi: 10.1126/scitranslmed.adw0721.
2
Virus glycoprotein nanodisc platform for vaccine design.用于疫苗设计的病毒糖蛋白纳米盘平台
bioRxiv. 2025 Jun 16:2025.05.02.651272. doi: 10.1101/2025.05.02.651272.
3
Vaccination with mRNA-encoded membrane-bound HIV Envelope trimer induces neutralizing antibodies in animal models.

本文引用的文献

1
N-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting.mRNA 的 N-甲基假尿嘧啶化导致+1 核糖体移码。
Nature. 2024 Jan;625(7993):189-194. doi: 10.1038/s41586-023-06800-3. Epub 2023 Dec 6.
2
Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.稳定突变对膜表达的 HIV-1 包膜糖蛋白的抗原表位和糖基化的影响。
PLoS Pathog. 2023 Aug 7;19(8):e1011452. doi: 10.1371/journal.ppat.1011452. eCollection 2023 Aug.
3
Protocol for analyzing antibody responses to glycoprotein antigens using electron-microscopy-based polyclonal epitope mapping.
用mRNA编码的膜结合HIV包膜三聚体进行疫苗接种可在动物模型中诱导产生中和抗体。
bioRxiv. 2025 Jan 25:2025.01.24.634423. doi: 10.1101/2025.01.24.634423.
基于电镜的多克隆表位作图分析糖蛋白抗原抗体反应的方案。
STAR Protoc. 2023 Sep 15;4(3):102476. doi: 10.1016/j.xpro.2023.102476. Epub 2023 Jul 28.
4
Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized mice.膜结合 mRNA 免疫原降低了在人源化小鼠中激活 HIV Env V2 顶点定向广谱中和 B 细胞前体的阈值。
Immunity. 2022 Nov 8;55(11):2168-2186.e6. doi: 10.1016/j.immuni.2022.09.003. Epub 2022 Sep 29.
5
mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice.mRNA 编码的 HIV-1 Env 三聚体铁蛋白纳米颗粒诱导小鼠产生中和异种 HIV-1 分离株的单克隆抗体。
Cell Rep. 2022 Mar 15;38(11):110514. doi: 10.1016/j.celrep.2022.110514.
6
The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization.HIV-1 包膜三聚体的聚糖孔区域显著促进了自体中和抗体的诱导。
J Virol. 2022 Jan 12;96(1):e0155221. doi: 10.1128/JVI.01552-21. Epub 2021 Oct 20.
7
DeGlyPHER: An Ultrasensitive Method for the Analysis of Viral Spike -Glycoforms.DeGlyPHER:一种分析病毒刺突糖型的超灵敏方法。
Anal Chem. 2021 Oct 12;93(40):13651-13657. doi: 10.1021/acs.analchem.1c03059. Epub 2021 Oct 1.
8
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge.COVID-19 疫苗 mRNA-1273 在小鼠中引发了保护性免疫谱,而在 SARS-CoV-2 挑战时,这种免疫谱与疫苗增强疾病无关。
Immunity. 2021 Aug 10;54(8):1869-1882.e6. doi: 10.1016/j.immuni.2021.06.018. Epub 2021 Jul 2.
9
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates.脂质纳米颗粒包裹的核苷修饰mRNA疫苗在非人灵长类动物中引发的多功能HIV-1抗体与蛋白质相当。
NPJ Vaccines. 2021 Apr 9;6(1):50. doi: 10.1038/s41541-021-00307-6.
10
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles.通过在双组分蛋白质纳米颗粒上展示Env三聚体进行免疫聚焦并增强自体2级HIV-1中和作用。
NPJ Vaccines. 2021 Feb 9;6(1):24. doi: 10.1038/s41541-021-00285-9.